Ignite Creation Date:
2024-06-16 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06444867
Status:
RECRUITING
Last Update Posted:
2024-06-06
First Post:
2024-05-30
Brief Title:
A Study to Evaluate Efficacy Safety Tolerability Pharmacokinetics and Pharmacodynamics of a Single Dose of LEO 158968
Sponsor:
LEO Pharma
Organization:
LEO Pharma
Study Overview
Official Title:
An Open-label Phase 1b Multi-site Trial to Evaluate the Efficacy Safety Tolerability Pharmacokinetics and Pharmacodynamics Following a Single Dose of LEO 158968 in Subjects With Gout Flares
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The main objective of the study is to evaluate the effect on pain of a single subcutaneous SC dose of LEO 158968 in participants with gout flares
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2023-508793-29 | EUDRACT_NUMBER | None | None |